NeoGenomics NEO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$17.11M-73.1% | -$9.88M+63.6% | -$27.13M+39.8% | -$45.09M-73.9% | -$25.92M-69.2% | ||
| $8.78M+0.2% | $8.76M-0.5% | $8.8M-3.7% | $9.14M-2.4% | $9.37M-4.7% | ||
| $9.64M+19.8% | $8.04M-22.0% | $10.31M-15.6% | $12.21M+13.6% | $10.75M+29.1% | ||
| $769K-71.5% | $2.69M— | —— | $993K+83.5% | $541K-65.2% | ||
| $8.18M+94.5% | $4.21M+77.7% | $2.37M+322% | -$1.07M-259% | $668K— | ||
| $1.27M+4,439% | $28K— | —— | $4.12M+36.3% | $3.02M+32.0% | ||
| $718K+111% | -$6.59M-13.1% | -$5.82M-189% | $6.58M+475% | $1.14M+128% | ||
| -$7M-70.9% | -$4.1M— | —— | —— | -$22.96M-323% | ||
| $1.4M+144% | -$3.21M-724% | $514K+126% | -$1.97M-163% | $3.11M-44.8% | ||
| $402K+223% | -$326K-195% | $343K+131% | -$1.11M-244% | $772K— | ||
| $7.63M0.0% | $7.63M0.0% | $7.63M-6.0% | $8.12M-2.8% | $8.36M0.0% | ||
| -$1.3M-5.4% | -$1.23M-55.1% | -$795K— | —— | -$1.09M+36.3% | ||
| -$8.14M-706% | $1.34M-84.9% | $8.88M-56.3% | $20.33M+180% | -$25.33M-358% | ||
| $5M-36.5% | $7.87M-5.3% | $8.31M+31.5% | $6.32M+40.5% | $4.5M-61.2% | ||
| $0— | $0-100% | $9M+200% | $3M-62.8% | $8.06M+31.4% | ||
| -$5M+20.7% | -$6.31M-2,176% | -$277K+97.0% | -$9.31M-362% | $3.56M— | ||
| -$338K-178% | $431K-43.7% | $765K+165% | -$1.18M-225% | $949K+38.1% | ||
| -$338K— | —— | —— | -$202.43M-21,431% | $949K+38.1% | ||
| -$13.48M-200% | -$4.5M— | $0+100% | -$191.47M-820% | -$20.82M-515% | ||
| $431K+43,000% | $1K-99.8% | $432K-65.6% | $1.26M+125,600% | $1K-99.9% | ||
| $0-100% | $57K— | $0-100% | $458K— | $0— | ||
| $7.63M0.0% | $7.63M0.0% | $7.63M-6.0% | $8.12M-2.8% | $8.36M0.0% | ||
| $8.78M+0.2% | $8.76M-0.5% | $8.8M-3.7% | $9.14M-2.4% | $9.37M-4.7% | ||
| $718K+111% | -$6.59M-13.1% | -$5.82M-189% | $6.58M+475% | $1.14M+128% | ||
| $769K-71.5% | $2.69M— | —— | $993K+83.5% | $541K-65.2% | ||
| -$1.3M-5.4% | -$1.23M-55.1% | -$795K— | —— | -$1.09M+36.3% | ||
| $1.4M+144% | -$3.21M-724% | $514K+126% | -$1.97M-163% | $3.11M-44.8% | ||
| —— | $125K0.0% | $125K0.0% | $125K0.0% | $125K— | ||
| $0— | $0-100% | $9M+200% | $3M-62.8% | $8.06M+31.4% | ||
| $4.32M+1,340% | $300K-39.9% | $499K— | —— | $1.38M— | ||
| —— | $7.5K0.0% | $7.5K0.0% | $7.5K0.0% | $7.5K+115% | ||
| -$1.3M-5.4% | -$1.23M-55.1% | -$795K— | —— | -$1.09M+36.3% | ||
| $1.72M+0.4% | $1.71M+1.6% | $1.69M-4.7% | $1.77M+11.7% | $1.58M-16.8% | ||
| —— | $516.5K0.0% | $516.5K0.0% | $516.5K0.0% | $516.5K— | ||
| —— | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M+937% | ||
| $0-100% | $57K— | $0-100% | $458K— | $0— | ||
| -$13.14M-101% | -$6.53M— | —— | —— | -$29.83M-1,558% | ||
| -$13.14M-101% | -$6.53M— | —— | —— | -$29.83M-1,558% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does NeoGenomics generate?
- NeoGenomics (NEO) generated $22.4M in operating cash flow over the trailing twelve months.
- What is NeoGenomics's free cash flow?
- After $27.5M of capital expenditures, NeoGenomics's free cash flow was -$51.3M over the trailing twelve months, down 19.8% year over year.
- Where does NeoGenomics's cash flow data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
